Icaritin, a Novel FASN Inhibitor, Exerts Anti-Melanoma Activities Through IGF-1R/STAT3 Signaling
Oncotarget - United States
doi 10.18632/oncotarget.9984
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 13, 2016
Authors
Publisher
Impact Journals, LLC